Recent Finacing
Recent Raise
Eyevensys develops a non-viral electrotransfection platform that delivers DNA plasmids into the ciliary muscle to express therapeutic proteins for ocular diseases such as uveitis, AMD, and retinitis pigmentosa.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Eyevensys.
